World Bank seeks board approval for $12 billion coronavirus vaccine financing plan
By David Lawder WASHINGTON (Reuters) - World Bank President David Malpass said on Tuesday he is seeking board approval for a $12 billion (£9.33 billion) coronavirus vaccine financing plan to help poor and developing countries secure a sufficient share of vaccine doses when they become available in the coming months. Malpass told Reuters in an exclusive interview that the initiative, part of $160 billion in coronavirus aid financing pledged by the multilateral lender, is aimed at helping countries procure and distribute vaccines early to healthcare and other essential workers and expand global production.
By David Lawder
WASHINGTON (Reuters) - World Bank President David Malpass said on Tuesday he is seeking board approval for a $12 billion (£9.33 billion) coronavirus vaccine financing plan to help poor and developing countries secure a sufficient share of vaccine doses when they become available in the coming months.
Malpass told Reuters in an exclusive interview that the initiative, part of $160 billion in coronavirus aid financing pledged by the multilateral lender, is aimed at helping countries procure and distribute vaccines early to healthcare and other essential workers and expand global production. He said the board was expected to consider the plan in early October.
Global competition for early coronavirus vaccine doses is already fierce, months ahead of any approvals, as wealthy countries move to secure supplies.
The U.S. government has pledged over $3 billion to secure hundreds of millions of doses of vaccines under development by Britain's AstraZeneca Plc
Malpass said the World Bank plan aimed to put poor and middle-income countries, where the virus is spreading most rapidly, on the same footing as richer countries by ensuring they have financing to secure supplies and a system for distribution, which will encourage drugmakers to meet their demand.
Without early doses that can bring outbreaks under control, many of these countries risk economic collapse that will push hundreds of millions of people back into poverty.
"Our goal is to alter the course of the pandemic for the low- and middle-income developing countries," Malpass said. "This is a market signal to the manufacturers that there will be financing available for the developing countries and there will be demand. We will begin asking the manufacturers to begin creating allocations for these countries."Malpass said the World Bank also was asking wealthy countries that have "over-reserved" more doses than they will ultimately need to release those doses to poorer countries.
He added that he is working to persuade countries that equitable distribution of vaccines "is important to the world and will give a better outcome for the world."
Separately, Brent McIntosh, U.S. Treasury undersecretary for international affairs, told a Foreign Policy magazine forum on Tuesday that wealthy countries were working on broad vaccine availability.
"There have been intense conversations among various developed countries on ensuring that there are vaccines available in the developing world and those conversations are ongoing at the highest levels," said McIntosh, who oversees U.S. involvement in the World Bank and the International Monetary Fund.
The World Bank program will disburse grant or loan funding to countries, and will be able to select any vaccine that meets safety criteria, including approval from multiple "highly respected, stringent regulatory agencies," such as those in the United States, Canada, Japan and several European countries, Malpass said.
The World Bank's private-sector arm, the International Financing Corp, in July launched a $4 billion financing platform to boost investment in developing country production of vaccines and other critical health products.
(Reporting by David Lawder; Editing by Lisa Shumaker, David Gregorio and Jonathan Oatis)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
By Jessica Resnick-Ault NEW YORK (Reuters) - Oil prices strengthened on Wednesday, as OPEC and its allies were seen complying with a pact to cut oil supply in September, even as concerns loomed that recovery in fuel demand will be stalled by soaring global coronavirus cases. Early in the day crude was boosted by a bullish stock market. Even as equities whipsawed on pandemic worries, oil stayed higher, buoyed by expectations that OPEC could staunch a supply glut
By Tina Bellon and C Nivedita (Reuters) - Tesla Inc will further cut the price of its Model S "Long Range" sedan in the United States to $69,420, the electric carmaker's chief executive, Elon Musk, announced in a tweet https://bit.ly/2H0JCP0 on Wednesday. The anticipated drop marks the second time this week Tesla has cut the price for the high-end sedan, following a 4% cut of the Model S's price in the United States on Tuesday to $71,990.
By Jeff Mason DES MOINES, Iowa (Reuters) - Under siege over his handling of the novel coronavirus pandemic, President Donald Trump on Wednesday cited what he said was his son's mild bout of the virus as a reason why American schools should reopen as soon as possible. Trump made the comment about his son, Barron, as the president swept into Iowa on a mission to shore up support in battleground states that he won in 2016 but is in danger of losing to Democrat Joe Biden barely three weeks before the election. First lady Melania Trump announced in a statement earlier in the day that the virus that struck both her and her husband had also infected their 14-year-old son